Liberate Medical, a company based outside of Louisville, Kentucky, won FDA Emergency Use Authorization for its VentFree Respiratory Muscle Stimulator that aims to reduce how long patients stay on ventilators. It works to keep the abdominal muscles from atrophying by delivering electric stimulation to the relevant muscles in tune with mechanical ventilation.
The device delivers stimulation in a non-invasive fashion and the therapy can be initiated immediately at the start of ventilation and continue until patients are weaned off ventilation.
Already, the manufacturer has partnered with other companies to help speed production and distribution of as many VentFrees as possible to ICUs around the country.
“We are delighted to have reached this milestone,” said Angus McLachlan, CEO of Liberate Medical in a press release. “We believe that the VentFree stimulator has the potential to meaningfully improve clinical outcomes in patients receiving mechanical ventilation. We look forward to engaging key opinion leader medical professionals throughout Europe for the introduction of this breakthrough technology.”
The device was cleared for use in the EU back in October of last year.
Product page: VentFree Respiratory Muscle Stimulator
more recommended stories
HEALEY Platform Accelerates ALS Therapy ResearchA New Era of ALS Clinical.
Low-Oxygen Therapy in a HypoxyStat Pill? Scientists Say It’s PossibleA New Approach to Oxygen Regulation-HypoxyStat.
Early Alzheimer’s Diagnosis with Advanced Tau TestA New Biomarker Test Promises Early.
AI and 3D Printing Unlock New Neuron Growth Insights3D-Printing Brain Model Unlocks Neuron Growth.
AI Uncovers Hidden Pregnancy Risks for StillbirthA groundbreaking AI-driven study has identified.
Harvard Study Unveils New TB Drug RegimensA Harvard Medical School-led clinical trial.
Affordable AI Tool Predicts Cancer Immunotherapy OutcomesResearchers from Memorial Sloan Kettering Cancer.
Inogen’s SIMEOX 200 Gets FDA Clearance for Airway CareInogen, Inc., a medical technology company.
AI System Tracks Emerging infectious DiseaseResearchers have developed a novel method.
Psilocybin Helps Reduce Anxiety, Depression During CancerGroundbreaking research from NYU Langone Health.
Leave a Comment